Explore our global cGMP-compliant portfolio of commercial active pharmaceutical ingredients, custom synthetic peptides, and advanced chemical intermediates tailored for tier-1 formulation laboratories.
Providing end-to-end pharmaceutical API manufacturing, strict regulatory filings, and global distribution infrastructure for commercial-scale deployment.
Triamterene (CAS No. 396-01-0; 2,4,7-triamino-6-phenylpteridine) is a well-established potassium-sparing diuretic that directly inhibits epithelial sodium channels (ENaC) in the distal convoluted tubule and collecting duct. For generic drug developers and formulation scientists, securing commercial-grade Triamterene API from trusted factories demands absolute control over physical polymorphs, impurity profiles, and synthetic yields.
| Analytical Parameter | EP / USP Standard Specification | Gentolex Factory cGMP Standard | Methodology / Analytical Equipment |
|---|---|---|---|
| Chemical Purity | 98.5% – 101.0% | ≥ 99.5% (HPLC Peak Area) | High-Performance Liquid Chromatography (RP-HPLC) |
| Related Substances | Impurity A ≤ 0.15%, Total ≤ 0.5% | Individual Specified < 0.05%, Total < 0.20% | LC-MS/MS Trace Impurity Profiling |
| Particle Size Distribution (PSD) | Customer Specific Requirement | Custom D90 < 10 μm (Micronized) available | Laser Diffraction (Malvern Mastersizer 3000) |
| Heavy Metals & Metal Catalyst | ≤ 20 ppm | ≤ 5 ppm | ICP-OES / ICP-MS Spectrometry |
| Polymorphic Form | Stable Form I | 100% Homogeneous Crystal Structure | Powder X-Ray Diffraction (PXRD) / DSC |
Historically, classical pteridine ring condensation routes presented significant waste-treatment burdens due to aromatic nitro intermediates and acidic solvents. Modern cGMP chemical manufacturing plants leverage catalytic hydrogenation steps using zero-waste recycled noble metal catalysts. By refining crystallization parameters through computer-assisted cooling curves, factories eliminate organic solvent inclusions while optimizing bulk density for immediate tableting and capsules manufacturing.
Hypertension, congestive heart failure, and edema remain leading drivers of global pharmaceutical procurement demand. Triamterene plays an indispensable role when formulated alongside thiazide diuretics (such as Hydrochlorothiazide). By dampening renal potassium excretion induced by thiazides, combination therapies optimize patient safety profiles, minimize arrhythmia risks, and enhance long-term treatment compliance.
Enabling stable oral dosage development. High bulk-density micronized Triamterene API ensures seamless blending uniformity with Hydrochlorothiazide, mitigating tablet capping or weight variation risks during high-speed tableting.
Different oral solid formats demand precise bioequivalence matching. Micronization options (D50 < 3 μm) dramatically elevate dissolution kinetics in poorly soluble media, providing key advantages for generic bioequivalence (BE) studies.
Global healthcare systems demand guaranteed supply continuity. Contract manufacturers and finished dosage facility partners gain direct access to reserve stock reservoirs and multi-site production redundancies.
Securing raw material APIs requires rigorous alignment with global health authority protocols. Strategic procurement managers navigating markets across the Americas, Europe, Asia-Pacific, and Africa require complete documentation suites to ensure frictionless regulatory submission.
Every batch of Triamterene API is accompanied by comprehensive regulatory support, including US FDA Type II DMF numbers, EDQM CEP certification paths, EU-GMP certificates, NMPA approval dossiers, WHO-cGMP compliance documentation, and stable long-term ICH stability data (Zone II & Zone IVb).
To bridge global timezone and regulatory variations, established local offices and representative teams—specifically established in key growth zones like Mexico and South Africa—provide localized sales support, customs clearing documentation, and immediate technical consultation.
Gentolex’s manufacturing ecosystem stands at the forefront of China's pharmaceutical Industry 4.0 evolution. Operating an overall factory construction footprint of 250,000 square meters designed under international standards, facilities are engineered to handle multi-ton commercial orders with high agility and zero compromise on compliance.
Fully automated Distributed Control Systems (DCS) monitor reaction parameters, temperatures, solvent feed rates, and pH levels in real time, virtually eliminating human operational error and batch-to-batch variations.
Equipped with thermal oxidizers (RTO) and advanced MVR wastewater treatment infrastructure, the plant guarantees regulatory stability and operational continuity free from environmental shutdown risks.
By synthesizing critical starting materials in-house or through dedicated long-term regional partnerships, raw material costs remain immune to geopolitical or market supply shocks.
For global pharmaceutical manufacturers, procurement is no longer just about transactional pricing—it requires strategic integration, inventory buffering, risk management, and flexible commercial frameworks.
We offer long-term supply agreements (LTSA), vendor-managed inventory (VMI) frameworks, spot-market bulk purchasing options, and tailored safety stock warehousing solutions near strategic transit hubs.
From 1kg trial R&D quantities to 25kg/50kg UN-approved fiber drums with double PE liners, packaging protocols are customized to preserve humidity integrity during transoceanic shipping.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
Dedicated R&D capabilities for continuous chemical process innovation, yield enhancement, analytical validation, and impurity synthesis.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
Introduction to Selank Acetate API Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed through neuropharmacological research, Selank is a derivative of the endogenous...
Trusted Thymosin Beta-4 API Manufacturer and Global Peptide Supplier As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies, pharmaceutical research organizations, and li...
Introduction BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, angiogenesis, and inflammatory regulation. As a peptide ac...
With the continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area of scientific investigation. Semax, a synthetic peptide derived from an ACTH fragment, has attracted attention among researchers due to its unique mol...
SS-31 API, also known as Elamipretide, MTP-131, Bendavia, and SS31, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane. By stabilizing mitochondrial structure and supporting cellular bioenergetics, SS-31 ha...
Essential technical and commercial insights for pharmaceutical procurement directors, QA/QC managers, and regulatory specialists.
Our standard commercial batches of Triamterene API consistently achieve HPLC purity exceeding 99.5%, far surpassing standard USP and EP pharmacopeial thresholds. Every batch is supplied with complete Certificate of Analysis (CoA) documentation detailing individual impurity profiles.
Yes. We offer particle size engineering tailored to customer oral dosage requirements. Our air-jet milling technology can achieve ultra-fine particle size distributions such as D90 < 10 μm or D50 < 3 μm with full PSD verification via Malvern Mastersizer 3000.
We provide complete Open Part/Applicant’s Part DMF documentation, ASMF technical structures, stability study reports under ICH Zone II and IVb, residual solvent analyses, BSE/TSE-free certificates, and cGMP compliance statements to facilitate national health authority registration.
Flexible minimum order quantities start from 1 kg for formulation R&D and scale to multi-ton commercial annual supply contracts. Standard commercial batch orders are dispatched within 2 to 3 weeks via express air cargo or temperature-monitored ocean freight.
We support both virtual desk audits and on-site cGMP plant inspections. Quality management personnel assist client audit teams with access to standard operating procedures (SOPs), equipment validation logs, cleaning validations, and environmental monitoring data.
Our local representatives assist clients with real-time technical consultation, local currency invoicing options, localized regulatory guidance, and rapid sample distribution to simplify cross-border sourcing in LATAM and African markets.
Browse additional high-demand active pharmaceutical ingredients, custom building blocks, and fine chemical solutions engineered to rigorous global standardizations.
